- Home
- CMMB vs TKLF Comparison
CMMB vs TKLF Comparison
Compare CMMB & TKLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- TKLF
- Stock Information
- Founded
- CMMB 2004
- TKLF 2006
- Country
- CMMB Israel
- TKLF Japan
- Employees
- CMMB N/A
- TKLF N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- TKLF Other Specialty Stores
- Sector
- CMMB Health Care
- TKLF Consumer Discretionary
- Exchange
- CMMB Nasdaq
- TKLF Nasdaq
- Market Cap
- CMMB 13.7M
- TKLF 15.6M
- IPO Year
- CMMB N/A
- TKLF 2022
- Fundamental
- Price
- CMMB $3.28
- TKLF $3.24
- Analyst Decision
- CMMB Strong Buy
- TKLF
- Analyst Count
- CMMB 2
- TKLF 0
- Target Price
- CMMB $26.50
- TKLF N/A
- AVG Volume (30 Days)
- CMMB 260.4K
- TKLF 155.3K
- Earning Date
- CMMB 11-13-2025
- TKLF 07-10-2025
- Dividend Yield
- CMMB N/A
- TKLF N/A
- EPS Growth
- CMMB N/A
- TKLF N/A
- EPS
- CMMB N/A
- TKLF 1.57
- Revenue
- CMMB N/A
- TKLF $210,119,238.00
- Revenue This Year
- CMMB N/A
- TKLF N/A
- Revenue Next Year
- CMMB N/A
- TKLF N/A
- P/E Ratio
- CMMB N/A
- TKLF $2.25
- Revenue Growth
- CMMB N/A
- TKLF 7.38
- 52 Week Low
- CMMB $2.39
- TKLF $2.20
- 52 Week High
- CMMB $9.84
- TKLF $5.80
- Technical
- Relative Strength Index (RSI)
- CMMB 59.76
- TKLF 32.87
- Support Level
- CMMB $3.03
- TKLF $3.65
- Resistance Level
- CMMB $3.50
- TKLF $3.71
- Average True Range (ATR)
- CMMB 0.21
- TKLF 0.21
- MACD
- CMMB 0.02
- TKLF -0.04
- Stochastic Oscillator
- CMMB 64.21
- TKLF 16.85
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About TKLF Yoshitsu Co. Ltd
Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.